Sutro Biopharma Other Current Assets (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

13.82 +0.75 (+5.74%) USD | NASDAQ | Jan 16, 16:00

14.09 +0.27 (+1.95%) Pre-Market: 08:59

View Other Current Assets (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Assets (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	Upgrade
Daré Bioscience, Inc.	--
Syndax Pharmaceuticals, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade